Developmental Biology Program

The Danwei Huangfu Lab

Research

Danwei Huangfu, PhD

We apply both precision gene editing and large-scale CRISPR screening in human pluripotent stem cells (hPSCs) to explore mechanisms underlying human development. Specifically, we are interrogating the protein-coding regulators of pancreatic development and β cell function. The pathways that regulate these processes can be exploited for therapeutics to prevent and reverse diseases such as type 1 and type 2 diabetes. In a second, closely related area, we are developing approaches to discover developmental enhancers, and to understand the epigenetic regulation of noncoding regulatory elements with a focus on DNA methylation.

View Lab Overview

View Reagents and Protocols

Featured News

Finding

Stem Cell Research Unlocks a New Discovery about Controlling Genes

Friday, April 9, 2021

In the Lab

Scientists Use CRISPR to Learn How Cells Make Decisions

Tuesday, July 2, 2019

Event

A Sneak Preview of Our Annual “Major Trends” Seminar Live Webcast

Monday, November 3, 2014

View All Featured News

Publications

QSER1 protects DNA methylation valleys from de novo methylation. Dixon G, Pan H, Yang D, Rosen BP, Jashari T, Verma N, Pulecio J, Caspi I, Lee K, Stransky S, Glezer A, Liu C, Rivas M, Kumar R, Lan Y, Torregroza I, He C, Sidoli S, Evans T, Elemento O, Huangfu D. Science. 2021 Apr 9;372(6538):eabd0875. doi: 10.1126/science.abd0875. [PMID: 33833093]

FOXA2 Is Required for Enhancer Priming during Pancreatic Differentiation. Lee K, Cho H, Rickert RW, Li QV, Pulecio J, Leslie CS, Huangfu D. Cell Rep. 2019;28(2):382-393.e7.

Genome-scale screens identify JNK-JUN signaling as a barrier for pluripotency exit and endoderm differentiation. Li QV, Dixon G, Verma N, Rosen BP, Gordillo M, Luo R, Xu C, Wang Q, Soh CL, Yang D, Crespo M, Shukla A, Xiang Q, Dündar F, Zumbo P, Witkin M, Koche R, Betel D, Chen S, Massagué J, Garippa R, Evans T, Beer MA, Huangfu D. Nat Genet. 2019;51(6):999-1010.

DICER1 Is Essential for Self-Renewal of Human Embryonic Stem Cells. Teijeiro V, Yang D, Majumdar S, González F, Rickert RW, Xu C, Koche R, Verma N, Lai EC, Huangfu D. Stem Cell Reports. 2018;11(3):616-625.

TET proteins safeguard bivalent promoters from de novo methylation in human embryonic stem cells. Verma N, Pan H, Doré LC, Shukla A, Li QV, Pelham-Webb B, Teijeiro V, González F, Krivtsov A, Chang CJ, Papapetrou EP, He C, Elemento O, Huangfu D. Nat Genet. 2018;50(1):83-95.

View All Publications

People

Danwei Huangfu, PhD

The Huangfu laboratory uses human pluripotent stem cells (hPSCs) as a powerful genetic model to interrogate the transcriptional and epigenetic mechanisms underlying cell fate decisions in development and disease.
PhD, Cornell University, Weill Graduate School of Medical Sciences
BS, Fudan University

huangfud@mskcc.org: Email Address
212-639-5239: Office Phone
Download CV: PDF File

Members

Jeyaram (Jey) Ravichandran Damodaran — Jeyaram Ravichandran Damodaran
Technician Research Assistant

Samuel Kaplan
Graduate Research Assistant

GSK Student — Dingyu Liu
Graduate Research Assistant

Lab Alumni

Tracey Leonardo

Research Technician

Qing Li, BS — Qing Li
Graduate Research Assistant

Abhijit Shukla

Research Fellow

Chew-Li Soh, PhD — Chew-Li Soh
Research Fellow

Virginia Teijeiro
Graduate Research Assistant

Daniela C. Georgieva
Research Technician

Federico Gonzalez-Grassi
Research Fellow

Katherine Lelli, PhD — Katherine Lelli
Research Fellow

Zengrong Zhu, PhD — Zengrong Zhu
Research Associate

Lab Affiliations

Achievements

Basil O’Connor Scholar, March of Dimes Birth Defects Foundation (2012-2014)
Louis V. Gerstner, Jr. Young Investigators Award, Memorial Sloan Kettering Cancer Center (2011-2014)
Award from Harvard Catalyst & InnoCentive for the Ideation Challenge on “What Do We Not Know to Cure Type 1 Diabetes” (2010)
Helen Hay Whitney Postdoctoral Fellowship (2006-2009)

Open Positions

Career Opportunities

Apply now

Get in Touch

huangfud@mskcc.org

Lab Head Email
212-639-5239

Office Phone
212-639-5240

Lab Phone

Disclosures

Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.

MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.

Danwei Huangfu discloses the following relationships and financial interests:

No disclosures meeting criteria for time period

The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.

This page and data include information for a specific MSK annual disclosure period (January 1, 2019 through disclosure submission in spring 2020). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at ecoi@mskcc.org.

View all disclosures